Financial Health Check: Examining Oncology Institute Inc (TOI)’s Key Ratios

Kiel Thompson

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

Oncology Institute Inc (NASDAQ: TOI) closed the day trading at $3.14 up 0.64% from the previous closing price of $3.12. In other words, the price has increased by $0.64 from its previous closing price. On the day, 0.97 million shares were traded. TOI stock price reached its highest trading level at $3.195 during the session, while it also had its lowest trading level at $3.065.

Upgrades & Downgrades

In the most recent recommendation for this company, Needham on November 25, 2025, initiated with a Buy rating and assigned the stock a target price of $5.

On July 23, 2025, Noble Capital Markets started tracking the stock assigning a Outperform rating and target price of $8. On July 16, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $6.B. Riley Securities initiated its Buy rating on July 16, 2025, with a $6 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’25 when Pacala Mark L sold 50,000 shares for $4.00 per share. The transaction valued at 200,000 led to the insider holds 174,971 shares of the business.

MARK PACALA bought 50,000 shares of TOI for $200,000 on Nov 18 ’25. On Sep 04 ’25, another insider, M33 Growth I L.P., who serves as the Director of the company, sold 6,018,168 shares for $3.09 each. As a result, the insider received 18,596,139 and left with 7,932,389 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOI now has a Market Capitalization of 308917440 and an Enterprise Value of 384883392. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.67. Its current Enterprise Value per Revenue stands at 0.835 whereas that against EBITDA is -11.292.

Stock Price History:

The Beta on a monthly basis for TOI is 0.21, which has changed by 19.128204 over the last 52 weeks, in comparison to a change of 0.1326145 over the same period for the S&P500. Over the past 52 weeks, TOI has reached a high of $4.88, while it has fallen to a 52-week low of $0.15. The 50-Day Moving Average of the stock is -17.07%, while the 200-Day Moving Average is calculated to be 11.35%.

Shares Statistics:

Over the past 3-months, TOI traded about 2.23M shares per day on average, while over the past 10 days, TOI traded about 3873290 shares per day. A total of 97.57M shares are outstanding, with a floating share count of 68.00M. Insiders hold about 30.34% of the company’s shares, while institutions hold 31.07% stake in the company. Shares short for TOI as of 1763078400 were 4450295 with a Short Ratio of 1.99, compared to 1760486400 on 5832046. Therefore, it implies a Short% of Shares Outstanding of 4450295 and a Short% of Float of 5.46.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.